The company formalises its 12-year presence in Saudi; It already operates over 40 Diaverum renal care clinics across 33 cities
M42
Latest in M42
Cancer treatments
M42, Toshiba partner for groundbreaking cancer treatment facility in Abu Dhabi
Construction of the new facility will begin in 2026 at Cleveland Clinic Abu Dhabi’s campus
genome research
M42 signals genomics expansion in strategic partnership with Uzbekistan’s health ministry
The partnership aims to collaborate in the fields of genomics, next-generation prevention, novel screening, and diagnostics development
Abu Dhabi
M42’s Diaverum ventures into UAE to offer advanced renal care solutions
The move marks the company’s efforts to expand its footprint in the Gulf region
Abu Dhabi
Abu Dhabi-based M42 partners with Rhapsody to enhance global health outcomes with Microsoft Azure
The announcement was made on day one of Arab Health 2025
Diabetes
Abu Dhabi’s IROS to collaborate in clinical study on obesity treatment
US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 diabetes in the UAE
M42
M42 partners with UAE Ministry of Defence to operate Zayed Military Hospital
The strategic partnership is set to provide healthcare access to over three million people across the UAE’s northern areas
Abu Dhabi
Abu Dhabi’s G42 and Mubadala combine healthcare assets to form M42
The tech-enabled, integrated healthcare company to have assets like Cleveland Clinic, Amana Healthcare, Biogenix Labs and Moorfields Eye Hospital among others